Chimin Health Management Hits Day Low at CNY 10.55 Amid Price Pressure

Chimin Health Management Co., Ltd. has experienced significant volatility in its stock performance, particularly on September 26, 2025, when it recorded a notable decline of 8.46%. The stock reached an intraday low of CNY 10.55, reflecting ongoing challenges within the company.
Over the past week, Chimin Health's performance has been particularly concerning, with a drop of 19.65%, contrasting sharply with the China Shanghai Composite's modest gain of 0.21%. While the company has shown a year-to-date increase of 57.73%, its long-term growth metrics raise questions. The company has reported a negative annual growth rate in net sales of 1.80% and a staggering decline in operating profit of 232.73% over the last five years.

Chimin Health's financial health is further underscored by a debt-to-equity ratio of 0.24, indicating a reliance on debt financing. Additionally, the company has faced challenges in profitability, with a return on equity of -9.61%. As it navigates these financial hurdles, the stock's performance continues to reflect the underlying pressures within the pharmaceuticals and biotechnology sector.